LP-284

LP-284 · Lantern Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LP-284, covering 2025-03-17 to 2025-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors [Phase 1]

See pricing